Clinical Trials Directory

Trials / Completed

CompletedNCT00473499

PEPCAD III Substudy: Stem Cell Mobilization

Paclitaxel-Eluting PTCA-Balloon in Combination With the Coroflex Blue Stent vs the Sirolimus Coated Cypher Stent in the Treatment of Advanced Coronary Artery Disease - Substudy Homburg/Saar

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
University Hospital, Saarland · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of the PEPCAD III substudy is to assess the efficacy of the Paclitaxel-eluting DEBlue stent system in the treatment of stenoses in native coronary arteries compared to the Sirolimus-eluting Cypher stent by intravascular ultrasound (IVUS) and to study the influence of both devices on endothelial function, coronary flow reserve, and stem cell mobilization.

Detailed description

The aim of the PEPCAD III substudy is to assess the efficacy of the DEBlue® Paclitaxel-eluting stent system in the treatment of stenoses in native coronary arteries compared to the Sirolimus-eluting Cypher stent by intravascular ultrasound (IVUS) and to study the influence of both devices on endothelial function, coronary flow reserve, and stem cell mobilization. This study is a prospective, randomized, single-center, two-armed phase-II study. During the PEPCAD III trial, 40 patients of the Homburg / Saar center will be randomly assigned to ei-ther one of the treatment groups (20 patients treated with DEBlue, 20 patients with Cypher®). Patients with stable or selected forms of unstable angina or documented ischemia due to a significant lesion in a native coronary artery will be included. Vessels may not supply an en-tirely infarcted myocardial area. Additional 20 patients receiving uncoated stents (Coroflex® Blue, B.Braun) will undergo the same diagnostic procedures.

Conditions

Interventions

TypeNameDescription
DEVICEDEBlue vs Cypher vs BMSBMS vs DES vs DEB+BMS

Timeline

Start date
2007-07-01
Primary completion
2009-03-01
Completion
2009-11-01
First posted
2007-05-15
Last updated
2010-06-30

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00473499. Inclusion in this directory is not an endorsement.